Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
Study sponsor: Aardvark Therapeutics, Inc. · AARD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-02-03Actual
Enrollment · participants12Actual
Source updated2025-02-11Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.